• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于评估帕金森病认知障碍的帕金森病认知评定量表:一项系统评价

Parkinson's Disease-Cognitive Rating Scale for Evaluating Cognitive Impairment in Parkinson's Disease: A Systematic Review.

作者信息

Rosca Elena Cecilia, Simu Mihaela

机构信息

Department of Neurology, Victor Babes University of Medicine and Pharmacy Timisoara, Eftimie Murgu Sq. No. 2, 300041 Timișoara, Romania.

Department of Neurology, Clinical Emergency County Hospital Timisoara, Bd. Iosif Bulbuca No. 10, 300736 Timisoara, Romania.

出版信息

Brain Sci. 2020 Aug 25;10(9):588. doi: 10.3390/brainsci10090588.

DOI:10.3390/brainsci10090588
PMID:32854426
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7565957/
Abstract

The aim of the present systematic review was to examine the evidence on the accuracy and psychometric properties of the Parkinson's Disease-Cognitive Rating Scale (PD-CRS) for evaluating the presence of cognitive impairment in patients with Parkinson's disease (PD) as well as to highlight the quality and quantity of research available on the use of the PD-CRS in this population. We searched four databases from inception until July 2020. Eight studies, published between 2008 and 2020, met the inclusion criteria: One cross-sectional study in which participants were assessed with the index test (PD-CRS) and a reference standard diagnostic assessment, in accordance with the Level II criteria of the International Parkinson and Movement Disorder Society (MDS); one case-control study comparing the PD-CRS to an extensive battery of tests (i.e., MDS Level II diagnosis); and six studies comparing the PD-CRS to other short cognitive batteries. In patients with Parkinson's disease, the PD-CRS test provides information about cortical and sub-cortical cognitive functions. Even if it demonstrated good psychometric properties, the results regarding the optimal threshold for detecting mild cognitive impairment and dementia in PD are somewhat inconsistent. Further cross-sectional studies are necessary to examine the optimum cut-off score for detecting cognitive dysfunction in PD patients.

摘要

本系统评价的目的是审查帕金森病认知评定量表(PD-CRS)在评估帕金森病(PD)患者认知障碍存在方面的准确性和心理测量特性的证据,并突出关于该人群使用PD-CRS的现有研究的质量和数量。我们检索了四个数据库,从创建至2020年7月。2008年至2020年间发表的八项研究符合纳入标准:一项横断面研究,根据国际帕金森和运动障碍协会(MDS)的二级标准,参与者接受了指标测试(PD-CRS)和参考标准诊断评估;一项病例对照研究,将PD-CRS与一系列广泛的测试(即MDS二级诊断)进行比较;以及六项将PD-CRS与其他简短认知测试组进行比较的研究。在帕金森病患者中,PD-CRS测试提供了有关皮质和皮质下认知功能的信息。即使它表现出良好的心理测量特性,但关于检测PD患者轻度认知障碍和痴呆的最佳阈值的结果仍有些不一致。需要进一步的横断面研究来检查检测PD患者认知功能障碍的最佳临界值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57bf/7565957/15c36660c8bd/brainsci-10-00588-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57bf/7565957/15c36660c8bd/brainsci-10-00588-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57bf/7565957/15c36660c8bd/brainsci-10-00588-g001.jpg

相似文献

1
Parkinson's Disease-Cognitive Rating Scale for Evaluating Cognitive Impairment in Parkinson's Disease: A Systematic Review.用于评估帕金森病认知障碍的帕金森病认知评定量表:一项系统评价
Brain Sci. 2020 Aug 25;10(9):588. doi: 10.3390/brainsci10090588.
2
Reliability, validity, and diagnostic accuracy of Parkinson's Disease-Cognitive Rating Scale in Iranian patients with idiopathic Parkinson's disease.帕金森病认知评定量表在伊朗特发性帕金森病患者中的信度、效度和诊断准确性。
Disabil Rehabil. 2022 May;44(10):2091-2098. doi: 10.1080/09638288.2020.1813337. Epub 2020 Sep 14.
3
The Parkinson's Disease-Cognitive Rating Scale (PD-CRS): normative values from 268 healthy Italian individuals.帕金森病认知评定量表(PD-CRS):268名健康意大利人的常模值
Neurol Sci. 2017 May;38(5):845-853. doi: 10.1007/s10072-017-2844-6. Epub 2017 Feb 21.
4
Parkinson's disease-cognitive rating scale: a new cognitive scale specific for Parkinson's disease.帕金森病认知评定量表:一种专门针对帕金森病的新型认知量表。
Mov Disord. 2008 May 15;23(7):998-1005. doi: 10.1002/mds.22007.
5
Accuracy of Two Cognitive Screening Tools to Detect Mild Cognitive Impairment in Parkinson's Disease.两种认知筛查工具检测帕金森病轻度认知障碍的准确性
Mov Disord Clin Pract. 2018 Mar 23;5(3):259-264. doi: 10.1002/mdc3.12597. eCollection 2018 May-Jun.
6
Psychometric properties and construct validity of the Parkinson's Disease-Cognitive Rating Scale (PD-CRS) in Colombia.帕金森病认知评定量表(PD-CRS)在哥伦比亚的心理测量特性及结构效度
Front Psychol. 2022 Dec 1;13:1018176. doi: 10.3389/fpsyg.2022.1018176. eCollection 2022.
7
An assessment of Movement Disorder Society Task Force diagnostic criteria for mild cognitive impairment in Parkinson's disease.帕金森病轻度认知障碍运动障碍学会工作组诊断标准评估。
Eur J Neurol. 2018 Jan;25(1):148-153. doi: 10.1111/ene.13467. Epub 2017 Oct 16.
8
Mapping brain morphology to cognitive deficits: a study on PD-CRS scores in Parkinson's disease with mild cognitive impairment.将脑形态与认知缺陷进行映射:一项关于帕金森病伴轻度认知障碍患者帕金森病认知评分量表(PD-CRS)评分的研究
Front Neuroanat. 2024 Aug 14;18:1362165. doi: 10.3389/fnana.2024.1362165. eCollection 2024.
9
Parkinson's disease-cognitive rating scale: psychometrics for mild cognitive impairment.帕金森病认知评定量表:用于轻度认知障碍的心理测量学。
Mov Disord. 2013 Sep;28(10):1376-83. doi: 10.1002/mds.25568. Epub 2013 Jul 19.
10
The Parkinson's Disease-Cognitive Rating Scale: Greek Normative Data, Clinical Utility and Cultural Considerations.帕金森病认知评定量表:希腊常模数据、临床效用和文化考量。
J Geriatr Psychiatry Neurol. 2022 Sep;35(5):680-688. doi: 10.1177/08919887211049110. Epub 2021 Oct 18.

引用本文的文献

1
The use of brain-machine interface, motor imagery, and action observation in the rehabilitation of individuals with Parkinson's disease: A protocol study for a randomized clinical trial.脑机接口、运动想象和动作观察在帕金森病患者康复中的应用:一项随机临床试验的方案研究
PLoS One. 2025 Apr 7;20(4):e0315148. doi: 10.1371/journal.pone.0315148. eCollection 2025.
2
Vocal Feature Changes for Monitoring Parkinson's Disease Progression-A Systematic Review.用于监测帕金森病进展的嗓音特征变化——一项系统综述
Brain Sci. 2025 Mar 19;15(3):320. doi: 10.3390/brainsci15030320.
3
Screening for Cognitive Impairment in Movement Disorders: Comparison of the Montreal Cognitive Assessment and Quick Mild Cognitive Impairment Screen in Parkinson's Disease and Lewy Body Dementia.

本文引用的文献

1
Montreal Cognitive Assessment for evaluating the cognitive impairment in patients with schizophrenia: A systematic review.蒙特利尔认知评估用于评估精神分裂症患者的认知障碍:系统评价。
Gen Hosp Psychiatry. 2020 Jul-Aug;65:64-73. doi: 10.1016/j.genhosppsych.2020.05.011. Epub 2020 May 29.
2
Validation of Revised Chinese Version of PD-CRS in Parkinson's Disease Patients.帕金森病患者中帕金森病认知功能评定量表修订中文版的效度验证
Parkinsons Dis. 2020 Feb 19;2020:5289136. doi: 10.1155/2020/5289136. eCollection 2020.
3
Early-stage Parkinson's patients show selective impairment in reactive but not proactive inhibition.
运动障碍中认知障碍的筛查:帕金森病和路易体痴呆中蒙特利尔认知评估与快速轻度认知障碍筛查的比较
J Alzheimers Dis Rep. 2024 Jun 21;8(1):971-980. doi: 10.3233/ADR-230207. eCollection 2024.
4
The Parkinson's Disease Composite of Executive Functioning: A Measure for Detecting Cognitive Decline in Clinical Trials.帕金森病执行功能综合量表:一种用于在临床试验中检测认知衰退的测量工具。
Neurology. 2024 Jul 23;103(2):e209609. doi: 10.1212/WNL.0000000000209609. Epub 2024 Jun 13.
5
Nonlinear Relationship Between Homocysteine and Mild Cognitive Impairment in Early Parkinson's Disease: A Cross-Sectional Study.早期帕金森病中同型半胱氨酸与轻度认知障碍的非线性关系:一项横断面研究
Neuropsychiatr Dis Treat. 2024 Apr 30;20:913-921. doi: 10.2147/NDT.S460938. eCollection 2024.
6
Controlling the Impact of -Related Hyperhomocysteinemia on Neurodegeneration.控制 - 相关高同型半胱氨酸血症对神经退行性变的影响。
Medicina (Kaunas). 2023 Mar 4;59(3):504. doi: 10.3390/medicina59030504.
7
Psychometric properties and construct validity of the Parkinson's Disease-Cognitive Rating Scale (PD-CRS) in Colombia.帕金森病认知评定量表(PD-CRS)在哥伦比亚的心理测量特性及结构效度
Front Psychol. 2022 Dec 1;13:1018176. doi: 10.3389/fpsyg.2022.1018176. eCollection 2022.
8
Can the prediction model using regression with optimal scale improve the power to predict the Parkinson's dementia?使用最优尺度回归的预测模型能否提高预测帕金森病痴呆的效能?
World J Psychiatry. 2022 Aug 19;12(8):1031-1043. doi: 10.5498/wjp.v12.i8.1031.
9
Astrogliosis in aging and Parkinson's disease dementia: a new clinical study with C-BU99008 PET.衰老和帕金森病痴呆中的星形胶质细胞增生:一项使用C-BU99008正电子发射断层扫描的新临床研究。
Brain Commun. 2022 Aug 18;4(5):fcac199. doi: 10.1093/braincomms/fcac199. eCollection 2022.
早期帕金森病患者在反应性而非主动性抑制方面表现出选择性损伤。
Mov Disord. 2020 Mar;35(3):409-418. doi: 10.1002/mds.27920. Epub 2019 Nov 21.
4
Montreal Cognitive Assessment (MoCA) for HIV-Associated Neurocognitive Disorders.蒙特利尔认知评估(MoCA)用于评估与 HIV 相关的神经认知障碍。
Neuropsychol Rev. 2019 Sep;29(3):313-327. doi: 10.1007/s11065-019-09412-9. Epub 2019 Aug 22.
5
Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review.帕金森病非运动症状治疗的研究进展——基于循证医学的评价
Mov Disord. 2019 Feb;34(2):180-198. doi: 10.1002/mds.27602. Epub 2019 Jan 17.
6
Complementary Therapies for Parkinson's Disease: What's Promoted, Rationale, Potential Risks and Benefits.帕金森病的补充疗法:推广内容、理论依据、潜在风险与益处
Mov Disord Clin Pract. 2015 Jun 29;2(3):205-212. doi: 10.1002/mdc3.12170. eCollection 2015 Sep.
7
Accuracy of Two Cognitive Screening Tools to Detect Mild Cognitive Impairment in Parkinson's Disease.两种认知筛查工具检测帕金森病轻度认知障碍的准确性
Mov Disord Clin Pract. 2018 Mar 23;5(3):259-264. doi: 10.1002/mdc3.12597. eCollection 2018 May-Jun.
8
Validation of the Parkinson's Disease-Cognitive Rating Scale Applying the Movement Disorder Society Task Force Criteria for Dementia Associated with Parkinson's Disease.应用运动障碍学会帕金森病相关痴呆工作组标准对帕金森病认知评定量表的验证
Mov Disord Clin Pract. 2016 Mar 1;4(1):51-57. doi: 10.1002/mdc3.12338. eCollection 2017 Jan-Feb.
9
Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.全球、地区和国家帕金森病负担,1990-2016 年:2016 年全球疾病负担研究的系统分析。
Lancet Neurol. 2018 Nov;17(11):939-953. doi: 10.1016/S1474-4422(18)30295-3. Epub 2018 Oct 1.
10
Validation of the MDS clinical diagnostic criteria for Parkinson's disease.MDS 临床帕金森病诊断标准的验证。
Mov Disord. 2018 Oct;33(10):1601-1608. doi: 10.1002/mds.27362. Epub 2018 Aug 25.